0
We're unable to sign you in at this time. Please try again in a few minutes.
Retry
We were able to sign you in, but your subscription(s) could not be found. Please try again in a few minutes.
Retry
There may be a problem with your account. Please contact the AMA Service Center to resolve this issue.
Contact the AMA Service Center:
Telephone: 1 (800) 262-2350 or 1 (312) 670-7827  *   Email: subscriptions@jamanetwork.com
Error Message ......
RSS Email Alerts
Please Wait... Processing your request... Please Wait.

News From the Food and Drug Administration | 
Rebecca Voelker, MSJ
JAMA. 2015;314(21):2227. doi:10.1001/jama.2015.15988.

Medical News & Perspectives | 
Julie A. Jacob, MA
JAMA. 2015;314(20):2117-2119. doi:10.1001/jama.2015.10795.

Viewpoint | 
James P. Allison, PhD
JAMA. 2015;314(11):1113-1114. doi:10.1001/jama.2015.11929.

Lab Reports | 
Tracy Hampton, PhD
JAMA. 2015;313(21):2114. doi:10.1001/jama.2015.5670.

Viewpoint | 
Euan A. Ashley, MRCP, DPhil
JAMA. 2015;313(21):2119-2120. doi:10.1001/jama.2015.3595.

Viewpoint | 
Xiaoliang Sunney Xie, PhD
JAMA. 2015;313(20):2021-2022. doi:10.1001/jama.2015.5533.

Viewpoint | 
Robert P. Perrillo, MD; Paul Martin, MD; Anna S. Lok, MD
JAMA. 2015;313(16):1617-1618. doi:10.1001/jama.2015.2571.

Viewpoint | 
Kitchener D. Wilson, MD, PhD; Joseph C. Wu, MD, PhD
JAMA. 2015;313(16):1613-1614. doi:10.1001/jama.2015.1846.

Medical News & Perspectives | 
Rita Rubin, MA
JAMA. 2015;313(11):1089-1091. doi:10.1001/jama.2015.0957.

Editorial | 
Howard L. McLeod, PharmD
JAMA. 2015;313(8):803-804. doi:10.1001/jama.2015.1086.

Sign in

Purchase Options

• Subscribe to the journal
• Rent this article ?

A free personal account provides

• Free current issues on The JAMA Network Reader
• Free quizzes on The JAMA Network Challenge
• Commenting and personalized alerts
From The JAMA Network
JAMA Oncology
Editorial  | 
AREG and EREG as Predictive Biomarkers for RAS Wild-Type Colorectal Cancer Treated With Panitumumab A Fresh Approach to an Old Puzzle
Elizabeth C. Smyth, MB, BCh, MSc; Khurum Khan, MBBS; David Cunningham, FMedSci
JAMA Oncology
Original Investigation  | 
Combined Epiregulin and Amphiregulin Expression Levels as a Predictive Biomarker for Panitumumab Therapy Benefit or Lack of Benefit in Patients With RAS Wild-Type Advanced Colorectal Cancer
Jenny F. Seligmann, PhD; Faye Elliott, MSc; Susan D. Richman, PhD; et al.
JAMA Oncology
Viewpoint  | 
Addressing Skyrocketing Cancer Drug Prices Comes With Tradeoffs Pick Your Poison
Scott D. Ramsey, MD, PhD; Gary H. Lyman, MD, MPH; Rick Bangs, MBA, PMP
JAMA Oncology
Brief Report  | 
Somatic Mosaic Mutations in PPM1D and TP53 in the Blood of Women With Ovarian Carcinoma
Elizabeth M. Swisher, MD; Maria I. Harrell, PhD; Barbara M. Norquist, MD; et al.